Log in

Biopharmx News Headlines (NYSEAMERICAN:BPMX)

$0.43
+0.06 (+16.22 %)
(As of 02/26/2020 06:00 AM ET)
Today's Range
$0.37
Now: $0.43
$0.45
50-Day Range
$0.31
MA: $0.35
$0.39
52-Week Range
$0.26
Now: $0.43
$4.46
Volume2.46 million shs
Average Volume1.85 million shs
Market Capitalization$7.86 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Biopharmx (NYSEAMERICAN BPMX) News Headlines

Source:
DateHeadline
Pharma Two B Appoints David S. Tierney, M.D. as the Company’s Chief Executive OfficerPharma Two B Appoints David S. Tierney, M.D. as the Company’s Chief Executive Officer
finance.yahoo.com - February 18 at 9:30 AM
Form 425 BioPharmX Corp Filed by: BioPharmX Corp - StreetInsider.comForm 425 BioPharmX Corp Filed by: BioPharmX Corp - StreetInsider.com
www.streetinsider.com - January 30 at 12:24 AM
The Daily Biotech Pulse: Novartis Earnings, Hepions NASH Candidate Beats Rival Drugs, Annovis Bio To Debut - Yahoo FinanceThe Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut - Yahoo Finance
finance.yahoo.com - January 29 at 2:24 PM
BioPharmX to merge with Timber Pharmaceuticals; shares up 9% after hours - Seeking AlphaBioPharmX to merge with Timber Pharmaceuticals; shares up 9% after hours - Seeking Alpha
seekingalpha.com - January 28 at 6:07 PM
BioPharmX And Timber Pharmaceuticals Announce Entry into Merger Agreement - PRNewswireBioPharmX And Timber Pharmaceuticals Announce Entry into Merger Agreement - PRNewswire
www.prnewswire.com - January 28 at 6:07 PM
BioPharmX To Present Phase 2b Clinical Trial Data at National DEF Essential Resource Meeting 2017BioPharmX To Present Phase 2b Clinical Trial Data at National DEF Essential Resource Meeting 2017
www.bloomberg.com - January 27 at 12:28 AM
BioPharmX Reports Fiscal Third Quarter 2020 Financial Results and Provides Corporate Update - PRNewswireBioPharmX Reports Fiscal Third Quarter 2020 Financial Results and Provides Corporate Update - PRNewswire
www.prnewswire.com - December 10 at 7:51 PM
BioPharmX Reports Fiscal Third Quarter 2020 Financial Results and Provides Corporate UpdateBioPharmX Reports Fiscal Third Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - December 10 at 7:51 PM
Papulopustular Rosacea Pipeline Insight Report, 2019 - ResearchAndMarkets.com - Yahoo FinancePapulopustular Rosacea Pipeline Insight Report, 2019 - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - October 16 at 12:45 PM
BioPharmX (BPMX) Receives Notice of Compliance Deadline Extension from NYSE American - StreetInsider.comBioPharmX (BPMX) Receives Notice of Compliance Deadline Extension from NYSE American - StreetInsider.com
www.streetinsider.com - September 22 at 2:05 PM
BioPharmX Receives Notice of Compliance Deadline Extension from NYSE American - PRNewswireBioPharmX Receives Notice of Compliance Deadline Extension from NYSE American - PRNewswire
www.prnewswire.com - September 21 at 12:28 PM
What Kind Of Investor Owns Most Of BioPharmX Corporation (NYSEMKT:BPMX)? - Yahoo FinanceWhat Kind Of Investor Owns Most Of BioPharmX Corporation (NYSEMKT:BPMX)? - Yahoo Finance
finance.yahoo.com - September 14 at 1:28 PM
What Kind Of Investor Owns Most Of BioPharmX Corporation (NYSEMKT:BPMX)?What Kind Of Investor Owns Most Of BioPharmX Corporation (NYSEMKT:BPMX)?
finance.yahoo.com - September 14 at 11:31 AM
BioPharmX Reports Fiscal Second Quarter 2020 Financial Results and Provides Corporate Update - Yahoo FinanceBioPharmX Reports Fiscal Second Quarter 2020 Financial Results and Provides Corporate Update - Yahoo Finance
finance.yahoo.com - September 10 at 12:44 PM
Form 8-K BioPharmX Corp For: Sep 09 - StreetInsider.comForm 8-K BioPharmX Corp For: Sep 09 - StreetInsider.com
www.streetinsider.com - September 9 at 3:49 PM
Form 10-Q BioPharmX Corp For: Jul 31 - StreetInsider.comForm 10-Q BioPharmX Corp For: Jul 31 - StreetInsider.com
www.streetinsider.com - September 9 at 3:49 PM
BioPharmX Reports Fiscal Second Quarter 2020 Financial Results and Provides Corporate Update - PRNewswireBioPharmX Reports Fiscal Second Quarter 2020 Financial Results and Provides Corporate Update - PRNewswire
www.prnewswire.com - September 9 at 3:49 PM
BioPharmX Reports Fiscal Second Quarter 2020 Financial Results and Provides Corporate UpdateBioPharmX Reports Fiscal Second Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - September 9 at 10:47 AM
BioPharmX Announces Steven M. Bosacki Joins the Company as Chief Operating Officer - Yahoo FinanceBioPharmX Announces Steven M. Bosacki Joins the Company as Chief Operating Officer - Yahoo Finance
finance.yahoo.com - July 18 at 8:39 AM
Did BioPharmX Corporation (NYSEMKT:BPMX) Insiders Sell Shares? - Yahoo FinanceDid BioPharmX Corporation (NYSEMKT:BPMX) Insiders Sell Shares? - Yahoo Finance
finance.yahoo.com - July 17 at 8:30 AM
BioPharmX (BPMX) Announces Steven M. Bosacki as COO - StreetInsider.comBioPharmX (BPMX) Announces Steven M. Bosacki as COO - StreetInsider.com
www.streetinsider.com - July 16 at 7:17 PM
BioPharmX Announces Steven M. Bosacki Joins the Company as Chief Operating OfficerBioPharmX Announces Steven M. Bosacki Joins the Company as Chief Operating Officer
finance.yahoo.com - July 16 at 7:17 PM
Did BioPharmX Corporation (NYSEMKT:BPMX) Insiders Sell Shares?Did BioPharmX Corporation (NYSEMKT:BPMX) Insiders Sell Shares?
finance.yahoo.com - July 16 at 3:36 PM
Why BioPharmX Collapsed After Announcing Positive NewsWhy BioPharmX Collapsed After Announcing Positive News
seekingalpha.com - June 27 at 11:41 AM
Biopharmx Gains from Tests - Baystreet.caBiopharmx Gains from Tests - Baystreet.ca
www.baystreet.ca - June 26 at 8:26 AM
Health Care Sector Update for 06/25/2019: BPMX,AGN,ABBV,CNAT,NVS - NasdaqHealth Care Sector Update for 06/25/2019: BPMX,AGN,ABBV,CNAT,NVS - Nasdaq
www.nasdaq.com - June 25 at 7:33 PM
Biopharmx Gains from TestsBiopharmx Gains from Tests
www.baystreet.ca - June 25 at 3:37 PM
BioPharmX Says Phase 2b Trial Met EndpointsBioPharmX Says Phase 2b Trial Met Endpoints
www.benzinga.com - June 25 at 3:37 PM
U.S. STOCKS ON THE MOVE-Acer Theraputics, AbbVie, BioPharmX - NasdaqU.S. STOCKS ON THE MOVE-Acer Theraputics, AbbVie, BioPharmX - Nasdaq
www.nasdaq.com - June 25 at 11:49 AM
Form 8-K BioPharmX Corp For: Jun 25 - StreetInsider.comForm 8-K BioPharmX Corp For: Jun 25 - StreetInsider.com
www.streetinsider.com - June 25 at 11:49 AM
BioPharmX Announces Positive Topline Results from Phase 2b Trial of BPX-04 for Papulopustular Rosacea - Yahoo FinanceBioPharmX Announces Positive Topline Results from Phase 2b Trial of BPX-04 for Papulopustular Rosacea - Yahoo Finance
finance.yahoo.com - June 25 at 11:49 AM
BioPharmX up 60% premarket on positive BPX-04 dataBioPharmX up 60% premarket on positive BPX-04 data
seekingalpha.com - June 25 at 11:40 AM
BioPharmX Announces Positive Topline Results from Phase 2b Trial of BPX-04 for Papulopustular RosaceaBioPharmX Announces Positive Topline Results from Phase 2b Trial of BPX-04 for Papulopustular Rosacea
finance.yahoo.com - June 25 at 11:40 AM
BioPharmX Reports Fiscal First Quarter 2020 Financial Results - PRNewswireBioPharmX Reports Fiscal First Quarter 2020 Financial Results - PRNewswire
www.prnewswire.com - June 12 at 10:15 AM
BioPharmX Reports Fiscal First Quarter 2020 Financial Results - Yahoo FinanceBioPharmX Reports Fiscal First Quarter 2020 Financial Results - Yahoo Finance
finance.yahoo.com - June 11 at 7:21 PM
BioPharmX Reports Fiscal First Quarter 2020 Financial ResultsBioPharmX Reports Fiscal First Quarter 2020 Financial Results
finance.yahoo.com - June 11 at 7:21 PM
BioPharmX Announces Last Patient Visit in Phase 2b Trial of BPX-04 for Papulopustular Rosacea - Yahoo FinanceBioPharmX Announces Last Patient Visit in Phase 2b Trial of BPX-04 for Papulopustular Rosacea - Yahoo Finance
finance.yahoo.com - May 24 at 8:24 AM
BioPharmX (BPMX) Reports Last Patient Visit in Phase 2b Trial of BPX-04 for Papulopustular Rosacea - StreetInsider.comBioPharmX (BPMX) Reports Last Patient Visit in Phase 2b Trial of BPX-04 for Papulopustular Rosacea - StreetInsider.com
www.streetinsider.com - May 22 at 7:18 PM
BioPharmX to report topline data on BPX-04 in early JulyBioPharmX to report topline data on BPX-04 in early July
seekingalpha.com - May 22 at 3:36 PM
BioPharmX Announces Last Patient Visit in Phase 2b Trial of BPX-04 for Papulopustular RosaceaBioPharmX Announces Last Patient Visit in Phase 2b Trial of BPX-04 for Papulopustular Rosacea
finance.yahoo.com - May 22 at 8:19 AM
BioPharmX down 15% after hours on stock sales agreement - Seeking AlphaBioPharmX down 15% after hours on stock sales agreement - Seeking Alpha
seekingalpha.com - May 17 at 8:21 AM
BioPharmX Completes 1-for-25 Reverse Stock Split - Yahoo FinanceBioPharmX Completes 1-for-25 Reverse Stock Split - Yahoo Finance
finance.yahoo.com - April 26 at 8:24 AM
BioPharmX Completes 1-for-25 Reverse Stock SplitBioPharmX Completes 1-for-25 Reverse Stock Split
finance.yahoo.com - April 26 at 8:24 AM
BioPharmX down 15% after hours on 1:25 reverse stock split - Seeking AlphaBioPharmX down 15% after hours on 1:25 reverse stock split - Seeking Alpha
seekingalpha.com - April 15 at 7:25 PM
BioPharmX Announces Reverse Stock SplitBioPharmX Announces Reverse Stock Split
finance.yahoo.com - April 15 at 7:25 PM
Research Report Identifies TTM Technologies, Zumiez, Global Net Lease, Catabasis Pharmaceuticals, BioPharmX, and Protalix BioTherapeutics with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement - GlobeNewswireResearch Report Identifies TTM Technologies, Zumiez, Global Net Lease, Catabasis Pharmaceuticals, BioPharmX, and Protalix BioTherapeutics with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement - GlobeNewswire
globenewswire.com - April 12 at 8:19 AM
BioPharmX Announces $3.9 Million Offering - PRNewswireBioPharmX Announces $3.9 Million Offering - PRNewswire
www.prnewswire.com - March 22 at 7:38 PM
BioPharmX Announces $3.9 Million OfferingBioPharmX Announces $3.9 Million Offering
finance.yahoo.com - March 21 at 11:33 AM
BioPharmX up 37% after corporate presentationBioPharmX up 37% after corporate presentation
seekingalpha.com - March 19 at 3:37 PM
Watch These Four Healthcare Stocks Set The Pace On TuesdayWatch These Four Healthcare Stocks Set The Pace On Tuesday
finance.yahoo.com - March 19 at 3:37 PM
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Featured Article: What are no-load funds?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel